How Much Is My Med Spa Worth in 2026?

A med spa is usually worth what a qualified buyer believes the business can sustain after closing, based on adjusted EBITDA, revenue quality, treatment mix, provider dependence, client recurrence, compliance structure, equipment obligations, and market demand.

In 2026, buyers are likely to look beyond top-line revenue and focus on whether earnings are transferable, providers can stay in place, patient demand is recurring, and the business can operate without the owner as the primary revenue driver.

Most med spa owners should not rely on a single revenue multiple or informal rule of thumb. A realistic valuation starts with normalized earnings, then adjusts for risk factors like medical director continuity, injector dependence, membership revenue, device leases, CPOM/MSO structure, location count, and buyer fit.

For a confidential estimate based on your own numbers, request a free med spa valuation.

What “valuation” actually means in M&A

When a sophisticated buyer values your med spa, they are not multiplying your revenue by a number. They are doing three things:

Rebuilding your financials. Your existing P&L is built for tax purposes — to minimize the income you report. A buyer needs the opposite: a P&L built to show the true earning power of the business. That means normalizing the owner’s compensation to market rate, adding back true one-time expenses (legal fees from a lawsuit, the build-out of your second location, the consultant you hired for a year), separating recurring from one-time revenue, and stripping personal expenses run through the business. The result is adjusted EBITDA — the number every multiple in this market is applied to.

Applying a multiple based on comparables. The buyer then reviews market context for similar businesses and applies a multiple of EBITDA. The multiple is not a guarantee or a reward for revenue alone — it is shorthand for how risky, transferable, and scalable the business looks to the buyer.

Discounting for risk and adjusting for opportunity. Finally, the buyer adjusts for the things they see: customer concentration, owner dependence, regulatory exposure, growth runway, working capital requirements, capital expenditure needs, and the cost of integration into their existing platform.

The headline number is the output of this process, not a quick estimate or a promise before diligence.

A transaction valuation is not the same as a general business evaluation. Medspa Business Evaluation vs. Valuation explains the difference and when each one is useful.

Illustrative Valuation Scenarios by Practice Profile

Source limitation: The figures below are hypothetical assumptions—not reported 2026 market statistics, a certified appraisal, or a disclosed comparable-transaction dataset. They illustrate how normalized earnings and risk may interact and should not be represented as typical buyer multiples or expected sale values.

These ranges are directional market context, not a certified appraisal or guarantee of buyer behavior. The range within each tier is wide — and where your business lands inside its tier depends on the risk and transferability factors buyers underwrite.

What Buyers May Weigh in a Valuation

Recurring-revenue quality, treatment concentration, owner and provider dependence, sustainable margin, growth quality, equipment obligations, and state-specific compliance can affect underwriting. Their effect is transaction-specific; no fixed service-mix percentage, membership threshold, margin benchmark, or multiple adjustment applies across med spas.

Using Market Evidence Carefully

Public filings and official datasets do not provide a comprehensive series of med spa transaction multiples. Any market claim should identify the transaction, measurement date, earnings definition, and consideration structure. Broader healthcare-services multiples should not be presented as med spa comparables without that support.

The mistakes that cost owners money

Three common owner-side mistakes show up in almost every conversation we have:

Using SDE instead of EBITDA. Seller’s discretionary earnings (SDE) is a small-business valuation metric that adds back the owner’s full compensation. It produces a higher number than EBITDA, which is why generalist business brokers love it. Sophisticated buyers don’t. If your “valuation” is built on SDE, the multiple a real buyer applies will be lower than you expect — and the headline number will collapse at LOI.

Counting one-time revenue as recurring. A patient who bought a six-treatment laser package is not a recurring patient. A patient who pays a monthly membership fee is. Buyers will separate the two during diligence regardless of how you present the numbers, so the only choice is whether to do the work yourself first.

Anchoring on a single buyer’s offer. A single unsolicited offer is, by definition, an offer made without broader market feedback. Owners should understand what qualified buyers may evaluate before treating one offer as the market.

Indicative valuation walkthrough

To make this concrete, here is how an indicative analysis might run for a sample practice profile:

Practice: Single-location med spa in a Tier-2 metro. Two injectors plus the owner-operator. $2.4M trailing twelve months revenue. Reported P&L EBITDA: $410K (17% margin). Owner takes a $180K salary. 12% of revenue from a membership program launched 18 months ago. 55% injectables, 18% lasers, 12% body, 10% skin, 5% other. 8% YoY growth.

Normalization:

• Owner compensation normalized down to market rate ($120K instead of $180K): +$60K
• One-time legal expense from a lease dispute: +$22K
• Personal vehicle and travel run through the business: +$18K
• Equipment that should have been capitalized but was expensed: +$31K
• Adjusted EBITDA: $541K (22.5% margin)

Directional market context:

• Tier: Established single location
• Range for tier: 4.5x – 6.5x
• Position adjustments:

– Membership program established but small (12% of revenue): mid-range

– Owner is a heavy injector but has two associates: slight discount

– Service mix is balanced: positive

– 8% growth is below the 10% threshold: slight discount

– EBITDA margin at 22.5% is normal: neutral

• Applied multiple: 5.0x – 5.5x

Indicative enterprise value: $2.7M – $3.0M

This is not a guarantee, certified appraisal, or prediction of final proceeds. It is an example of how a qualified buyer may frame risk, earnings quality, and transferability before diligence and negotiation.

How to use this guide

Three things to do with the information above:

1. Estimate your tier. Find the row in the table that matches your revenue and approximate EBITDA. That’s your starting range.

2. Apply the value drivers. Walk through the six factors. Each one you have moves you up inside the tier; each one you’re missing moves you down.

3. Get an owner-specific valuation discussion. A self-assessment is a starting point, not a finished product. The next step is confidential valuation guidance from someone who understands med spa transactions, buyer diligence, and sale readiness.

Frequently asked questions

Is SDE the same as EBITDA?

No. SDE and adjusted EBITDA are different, non-GAAP earnings conventions. SDE is often used for owner-operated businesses; adjusted EBITDA is often used in larger transactions. The appropriate measure and normalization depend on the buyer, deal size, owner’s role, and replacement-cost assumptions. The SEC’s non-GAAP guidance reinforces the need to define and reconcile adjusted measures clearly.

Do buyers really pay 10x+ EBITDA for med spas?

Exceptional multiples can occur, but no comprehensive public dataset supports a categorical threshold for med spas. Any claimed comparable should be checked for business profile, earnings definition, cash at close, contingent consideration, and transaction date.

How long does a real valuation take?

An initial confidential valuation discussion can usually begin once basic financials and operating context are available. A more detailed valuation range may require normalized financials, recurring revenue analysis, service mix review, provider continuity analysis, and preparation for buyer diligence.

Can my valuation change in six months?

Yes, in both directions. The two biggest drivers of change are your trailing trend (a strong six months pulls the number up; a weak six months pulls it down) and the broader market environment. Market multiples have moved meaningfully in both directions over the past three years. Locking in a process at the right time is part of the value of a specialist advisor.

Related Questions Med Spa Owners Ask

Should I use revenue or profit to estimate value?

Buyers usually anchor value to normalized earnings, not revenue alone. Revenue quality still affects the risk and multiple applied.

When is SDE more useful than EBITDA?

Seller’s discretionary earnings often suits an owner-operated med spa where one owner’s compensation and benefits are central. EBITDA is generally more useful when management costs are already reflected.

How does treatment mix affect value?

Buyers compare margins, repeat frequency, provider requirements, seasonality, and regulatory exposure. A diversified, defensible mix may reduce risk.

Are devices added to valuation separately?

Usually not when they are necessary to generate the earnings being valued. Leases, debt, liens, age, utilization, and replacement costs still affect proceeds and risk.

What improves confidence in a med spa valuation?

Reconciled financials, documented adjustments, organized contracts, clear management-services and professional-entity relationships, and lower dependence on one owner or provider make earnings easier to underwrite.

---

Related reading:

• Confidential Med Spa Sale Process — seller process overview
• Med Spa EBITDA Multiples: 2026 Market Data
• What Med Spa Buyers Actually Look For
• How to Sell a Med Spa: A Step-by-Step Guide